| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Minimally Invasive Surgical Procedures | 96 | 2023 | 307 | 16.640 |
Why?
|
| Spinal Fusion | 70 | 2023 | 461 | 10.610 |
Why?
|
| Lumbar Vertebrae | 59 | 2023 | 385 | 9.080 |
Why?
|
| Diskectomy | 29 | 2022 | 182 | 5.910 |
Why?
|
| Thoracic Vertebrae | 27 | 2018 | 89 | 5.610 |
Why?
|
| Neurosurgical Procedures | 26 | 2021 | 145 | 5.240 |
Why?
|
| Decompression, Surgical | 23 | 2017 | 124 | 5.130 |
Why?
|
| Intervertebral Disc Displacement | 24 | 2022 | 83 | 4.900 |
Why?
|
| Spine | 23 | 2021 | 103 | 4.880 |
Why?
|
| Scoliosis | 15 | 2023 | 34 | 4.280 |
Why?
|
| Postoperative Complications | 47 | 2023 | 893 | 4.030 |
Why?
|
| Spinal Cord Injuries | 9 | 2023 | 37 | 3.710 |
Why?
|
| Cervical Vertebrae | 20 | 2022 | 287 | 3.660 |
Why?
|
| Spinal Diseases | 18 | 2021 | 112 | 3.450 |
Why?
|
| Treatment Outcome | 76 | 2023 | 3339 | 3.120 |
Why?
|
| Lordosis | 14 | 2022 | 41 | 3.040 |
Why?
|
| Humans | 190 | 2023 | 25900 | 2.950 |
Why?
|
| Endoscopy | 16 | 2012 | 176 | 2.950 |
Why?
|
| Spinal Stenosis | 9 | 2015 | 35 | 2.810 |
Why?
|
| Middle Aged | 109 | 2023 | 8556 | 2.740 |
Why?
|
| Spondylolisthesis | 12 | 2023 | 41 | 2.680 |
Why?
|
| Intervertebral Disc Degeneration | 7 | 2022 | 83 | 2.560 |
Why?
|
| Female | 115 | 2023 | 14543 | 2.380 |
Why?
|
| Microsurgery | 13 | 2022 | 42 | 2.320 |
Why?
|
| Radiculopathy | 7 | 2022 | 42 | 2.250 |
Why?
|
| Male | 111 | 2023 | 14176 | 2.250 |
Why?
|
| Spinal Cord Compression | 10 | 2016 | 23 | 2.150 |
Why?
|
| Spinal Cord Neoplasms | 8 | 2015 | 29 | 2.090 |
Why?
|
| Spondylosis | 7 | 2019 | 27 | 2.030 |
Why?
|
| Laminectomy | 10 | 2014 | 42 | 1.980 |
Why?
|
| Aged | 79 | 2023 | 8658 | 1.980 |
Why?
|
| Retrospective Studies | 51 | 2023 | 3342 | 1.940 |
Why?
|
| Adult | 80 | 2023 | 7517 | 1.870 |
Why?
|
| Spinal Curvatures | 9 | 2020 | 13 | 1.770 |
Why?
|
| Bone Screws | 13 | 2017 | 142 | 1.660 |
Why?
|
| Orthopedic Procedures | 7 | 2018 | 314 | 1.630 |
Why?
|
| Spinal Cord | 8 | 2023 | 76 | 1.630 |
Why?
|
| Patient Reported Outcome Measures | 4 | 2021 | 501 | 1.550 |
Why?
|
| Foraminotomy | 4 | 2019 | 8 | 1.540 |
Why?
|
| Pedicle Screws | 3 | 2015 | 12 | 1.380 |
Why?
|
| Fluoroscopy | 6 | 2016 | 42 | 1.220 |
Why?
|
| Length of Stay | 13 | 2021 | 307 | 1.180 |
Why?
|
| Quality of Life | 8 | 2021 | 563 | 1.160 |
Why?
|
| Low Back Pain | 5 | 2015 | 129 | 1.140 |
Why?
|
| Prostheses and Implants | 5 | 2009 | 152 | 1.040 |
Why?
|
| Intervertebral Disc | 5 | 2010 | 119 | 1.000 |
Why?
|
| Spinal Neoplasms | 7 | 2013 | 36 | 1.000 |
Why?
|
| Sacrum | 5 | 2018 | 20 | 0.990 |
Why?
|
| Patient Satisfaction | 2 | 2021 | 314 | 0.990 |
Why?
|
| Follow-Up Studies | 27 | 2021 | 1708 | 0.990 |
Why?
|
| Embolization, Therapeutic | 3 | 2022 | 54 | 0.980 |
Why?
|
| Spinal Fractures | 7 | 2009 | 43 | 0.930 |
Why?
|
| Mental Health | 3 | 2021 | 107 | 0.920 |
Why?
|
| Back Pain | 11 | 2023 | 61 | 0.920 |
Why?
|
| Spinal Cord Diseases | 5 | 2013 | 47 | 0.880 |
Why?
|
| Diskectomy, Percutaneous | 3 | 2010 | 6 | 0.850 |
Why?
|
| Pain Measurement | 13 | 2021 | 477 | 0.820 |
Why?
|
| Intraoperative Neurophysiological Monitoring | 2 | 2021 | 7 | 0.820 |
Why?
|
| Bone Transplantation | 5 | 2015 | 203 | 0.810 |
Why?
|
| Intraoperative Complications | 3 | 2015 | 65 | 0.810 |
Why?
|
| Drainage | 1 | 2023 | 44 | 0.810 |
Why?
|
| Dura Mater | 3 | 2020 | 19 | 0.800 |
Why?
|
| Dysbiosis | 1 | 2023 | 46 | 0.790 |
Why?
|
| Oligodendrocyte Precursor Cells | 1 | 2022 | 1 | 0.780 |
Why?
|
| Cervical Cord | 1 | 2022 | 1 | 0.780 |
Why?
|
| Neck Injuries | 1 | 2022 | 3 | 0.780 |
Why?
|
| Magnetic Resonance Imaging | 17 | 2017 | 1071 | 0.750 |
Why?
|
| Atlanto-Occipital Joint | 3 | 2015 | 13 | 0.690 |
Why?
|
| Spinal Osteophytosis | 3 | 2007 | 9 | 0.680 |
Why?
|
| Radiography | 21 | 2017 | 611 | 0.670 |
Why?
|
| Motivation | 1 | 2020 | 89 | 0.660 |
Why?
|
| Cellular Reprogramming | 1 | 2020 | 2 | 0.660 |
Why?
|
| Pluripotent Stem Cells | 1 | 2020 | 6 | 0.660 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2020 | 18 | 0.640 |
Why?
|
| Cohort Studies | 10 | 2021 | 1815 | 0.640 |
Why?
|
| Disability Evaluation | 12 | 2018 | 257 | 0.630 |
Why?
|
| Kyphosis | 5 | 2020 | 21 | 0.630 |
Why?
|
| Reoperation | 15 | 2020 | 912 | 0.610 |
Why?
|
| Aged, 80 and over | 22 | 2021 | 4633 | 0.610 |
Why?
|
| Neurodegenerative Diseases | 1 | 2020 | 124 | 0.610 |
Why?
|
| Prospective Studies | 13 | 2021 | 1686 | 0.600 |
Why?
|
| Blood Loss, Surgical | 7 | 2015 | 54 | 0.580 |
Why?
|
| Patient Readmission | 2 | 2017 | 128 | 0.570 |
Why?
|
| Ependymoma | 2 | 2009 | 14 | 0.570 |
Why?
|
| Osteotomy | 3 | 2019 | 172 | 0.570 |
Why?
|
| Natural Orifice Endoscopic Surgery | 1 | 2017 | 2 | 0.540 |
Why?
|
| Muscular Diseases | 1 | 2017 | 13 | 0.540 |
Why?
|
| Video Recording | 2 | 2013 | 31 | 0.530 |
Why?
|
| Pyramidal Tracts | 1 | 2016 | 3 | 0.520 |
Why?
|
| Wounds, Gunshot | 1 | 2016 | 3 | 0.520 |
Why?
|
| Young Adult | 11 | 2018 | 1929 | 0.520 |
Why?
|
| Brown-Sequard Syndrome | 1 | 2016 | 4 | 0.520 |
Why?
|
| Central Nervous System Vascular Malformations | 1 | 2016 | 3 | 0.520 |
Why?
|
| Age of Onset | 1 | 2016 | 95 | 0.510 |
Why?
|
| Foreign-Body Migration | 2 | 2015 | 16 | 0.510 |
Why?
|
| Tomography, X-Ray Computed | 10 | 2016 | 631 | 0.500 |
Why?
|
| Atlanto-Axial Joint | 2 | 2015 | 11 | 0.490 |
Why?
|
| Health Care Costs | 2 | 2016 | 69 | 0.490 |
Why?
|
| Spondylolysis | 1 | 2015 | 3 | 0.480 |
Why?
|
| Propensity Score | 3 | 2023 | 31 | 0.480 |
Why?
|
| Postoperative Care | 6 | 2021 | 134 | 0.460 |
Why?
|
| Neurosurgery | 3 | 2015 | 39 | 0.460 |
Why?
|
| Thoracoscopy | 3 | 2014 | 22 | 0.460 |
Why?
|
| Athletes | 1 | 2015 | 87 | 0.450 |
Why?
|
| Quality of Health Care | 1 | 2015 | 96 | 0.450 |
Why?
|
| Hypothermia, Induced | 1 | 2014 | 15 | 0.440 |
Why?
|
| Adolescent | 12 | 2023 | 2070 | 0.440 |
Why?
|
| Neuroendoscopy | 2 | 2013 | 7 | 0.430 |
Why?
|
| Hernia | 1 | 2014 | 9 | 0.430 |
Why?
|
| Osteoporosis | 2 | 2006 | 74 | 0.420 |
Why?
|
| Herniorrhaphy | 1 | 2014 | 29 | 0.420 |
Why?
|
| Parkinson Disease | 1 | 2020 | 664 | 0.420 |
Why?
|
| Cerebrospinal Fluid Rhinorrhea | 1 | 2013 | 14 | 0.420 |
Why?
|
| Functional Laterality | 1 | 2013 | 62 | 0.410 |
Why?
|
| Vertebroplasty | 2 | 2009 | 8 | 0.400 |
Why?
|
| Spinal Nerve Roots | 4 | 2003 | 14 | 0.400 |
Why?
|
| Nerve Compression Syndromes | 4 | 2003 | 17 | 0.400 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2013 | 196 | 0.390 |
Why?
|
| Sarcoma, Myeloid | 1 | 2012 | 4 | 0.380 |
Why?
|
| Databases, Factual | 8 | 2018 | 328 | 0.380 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2012 | 36 | 0.370 |
Why?
|
| Syringomyelia | 3 | 2007 | 6 | 0.370 |
Why?
|
| Obesity | 2 | 2015 | 292 | 0.340 |
Why?
|
| Zygapophyseal Joint | 3 | 2006 | 27 | 0.320 |
Why?
|
| Posture | 4 | 2018 | 60 | 0.320 |
Why?
|
| Costs and Cost Analysis | 3 | 2019 | 34 | 0.320 |
Why?
|
| Intracranial Aneurysm | 1 | 2009 | 36 | 0.310 |
Why?
|
| Carcinoma in Situ | 1 | 2009 | 9 | 0.310 |
Why?
|
| Stents | 1 | 2009 | 64 | 0.310 |
Why?
|
| Surgical Wound Infection | 1 | 2009 | 85 | 0.300 |
Why?
|
| Checklist | 2 | 2023 | 31 | 0.300 |
Why?
|
| Cadaver | 5 | 2009 | 375 | 0.290 |
Why?
|
| Age Factors | 4 | 2018 | 738 | 0.290 |
Why?
|
| Evoked Potentials, Motor | 3 | 2021 | 10 | 0.280 |
Why?
|
| Subarachnoid Space | 1 | 2007 | 4 | 0.280 |
Why?
|
| Cerebrospinal Fluid Shunts | 1 | 2007 | 7 | 0.280 |
Why?
|
| Congenital Abnormalities | 2 | 2017 | 6 | 0.280 |
Why?
|
| Pseudarthrosis | 3 | 2011 | 9 | 0.280 |
Why?
|
| Recurrence | 5 | 2012 | 290 | 0.270 |
Why?
|
| Models, Biological | 2 | 2009 | 285 | 0.270 |
Why?
|
| Rhizotomy | 1 | 2006 | 2 | 0.260 |
Why?
|
| Range of Motion, Articular | 4 | 2015 | 719 | 0.250 |
Why?
|
| Cysts | 1 | 2006 | 13 | 0.250 |
Why?
|
| Biomechanical Phenomena | 4 | 2015 | 639 | 0.250 |
Why?
|
| Intermittent Claudication | 1 | 2006 | 3 | 0.250 |
Why?
|
| Evoked Potentials, Somatosensory | 3 | 2021 | 8 | 0.250 |
Why?
|
| Arthroplasty | 2 | 2022 | 159 | 0.250 |
Why?
|
| Incidence | 4 | 2015 | 720 | 0.250 |
Why?
|
| Paralysis | 2 | 2023 | 15 | 0.240 |
Why?
|
| Nervous System Diseases | 3 | 2012 | 118 | 0.240 |
Why?
|
| Lumbosacral Region | 5 | 2017 | 57 | 0.240 |
Why?
|
| Feasibility Studies | 6 | 2009 | 200 | 0.240 |
Why?
|
| Electric Stimulation Therapy | 2 | 2003 | 40 | 0.230 |
Why?
|
| Movement | 1 | 2005 | 110 | 0.230 |
Why?
|
| Pelvis | 3 | 2018 | 26 | 0.220 |
Why?
|
| Time Factors | 5 | 2013 | 1376 | 0.210 |
Why?
|
| Tuberculosis, Spinal | 1 | 2003 | 1 | 0.200 |
Why?
|
| Cell Differentiation | 2 | 2020 | 134 | 0.200 |
Why?
|
| Decompression | 1 | 2023 | 23 | 0.200 |
Why?
|
| Intervertebral Disc Chemolysis | 1 | 2003 | 6 | 0.200 |
Why?
|
| Frailty | 1 | 2023 | 30 | 0.200 |
Why?
|
| Central Nervous System | 1 | 2023 | 55 | 0.200 |
Why?
|
| Electromyography | 2 | 2021 | 71 | 0.200 |
Why?
|
| Surgery, Computer-Assisted | 2 | 2016 | 51 | 0.200 |
Why?
|
| Tacrolimus | 1 | 2022 | 8 | 0.200 |
Why?
|
| Recovery of Function | 3 | 2015 | 296 | 0.190 |
Why?
|
| Varicose Veins | 1 | 2022 | 1 | 0.190 |
Why?
|
| Hypesthesia | 1 | 2022 | 5 | 0.190 |
Why?
|
| Pain | 3 | 2020 | 401 | 0.190 |
Why?
|
| Decision Making | 2 | 2014 | 214 | 0.180 |
Why?
|
| Benzophenones | 1 | 2021 | 25 | 0.180 |
Why?
|
| Internal Fixators | 3 | 2004 | 37 | 0.180 |
Why?
|
| Polymers | 1 | 2021 | 42 | 0.180 |
Why?
|
| Fracture Fixation, Internal | 2 | 1999 | 58 | 0.180 |
Why?
|
| Polyethylene Glycols | 1 | 2021 | 38 | 0.180 |
Why?
|
| Convalescence | 1 | 2020 | 5 | 0.170 |
Why?
|
| Muscle, Skeletal | 2 | 2017 | 378 | 0.170 |
Why?
|
| Leg | 1 | 2020 | 48 | 0.170 |
Why?
|
| Genomic Instability | 1 | 2020 | 9 | 0.170 |
Why?
|
| Regenerative Medicine | 1 | 2020 | 5 | 0.170 |
Why?
|
| Postoperative Period | 3 | 2017 | 331 | 0.160 |
Why?
|
| Allografts | 1 | 2021 | 211 | 0.160 |
Why?
|
| Cervical Atlas | 1 | 1999 | 4 | 0.160 |
Why?
|
| Algorithms | 3 | 2019 | 337 | 0.160 |
Why?
|
| Axis, Cervical Vertebra | 1 | 1999 | 9 | 0.160 |
Why?
|
| Models, Anatomic | 2 | 2010 | 37 | 0.160 |
Why?
|
| Minimal Clinically Important Difference | 1 | 2021 | 166 | 0.160 |
Why?
|
| Biocompatible Materials | 1 | 2020 | 88 | 0.160 |
Why?
|
| Neck | 1 | 2019 | 26 | 0.150 |
Why?
|
| Bone Plates | 1 | 2019 | 45 | 0.150 |
Why?
|
| Finite Element Analysis | 2 | 2009 | 29 | 0.150 |
Why?
|
| Joint Instability | 4 | 2000 | 395 | 0.150 |
Why?
|
| Rehabilitation Centers | 1 | 2018 | 2 | 0.150 |
Why?
|
| Patient Selection | 1 | 2019 | 182 | 0.150 |
Why?
|
| Home Care Services | 1 | 2018 | 22 | 0.150 |
Why?
|
| Operative Time | 2 | 2016 | 84 | 0.140 |
Why?
|
| Analgesics, Opioid | 1 | 2021 | 228 | 0.140 |
Why?
|
| Diagnosis-Related Groups | 1 | 2017 | 8 | 0.140 |
Why?
|
| Cost-Benefit Analysis | 2 | 2015 | 123 | 0.140 |
Why?
|
| Anemia | 1 | 2017 | 31 | 0.140 |
Why?
|
| Blood Transfusion | 1 | 2017 | 62 | 0.140 |
Why?
|
| Muscle Denervation | 1 | 2017 | 3 | 0.140 |
Why?
|
| Constriction, Pathologic | 1 | 2017 | 26 | 0.130 |
Why?
|
| Single-Blind Method | 1 | 2017 | 100 | 0.130 |
Why?
|
| Medicare | 1 | 2017 | 116 | 0.130 |
Why?
|
| Intensive Care Units | 1 | 2019 | 261 | 0.130 |
Why?
|
| Activities of Daily Living | 1 | 2020 | 584 | 0.130 |
Why?
|
| Angiography, Digital Subtraction | 1 | 2016 | 9 | 0.130 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2017 | 161 | 0.130 |
Why?
|
| Arthroscopy | 1 | 2005 | 1105 | 0.130 |
Why?
|
| Musculoskeletal Abnormalities | 1 | 2015 | 1 | 0.120 |
Why?
|
| Risk Factors | 4 | 2016 | 2173 | 0.120 |
Why?
|
| Nerve Degeneration | 1 | 1996 | 47 | 0.120 |
Why?
|
| Quality Indicators, Health Care | 1 | 2015 | 28 | 0.120 |
Why?
|
| Fetal Tissue Transplantation | 3 | 2001 | 22 | 0.120 |
Why?
|
| Defensive Medicine | 1 | 2015 | 1 | 0.120 |
Why?
|
| Health Surveys | 1 | 2015 | 85 | 0.120 |
Why?
|
| Narcotics | 3 | 2005 | 38 | 0.110 |
Why?
|
| Brain Diseases | 2 | 2000 | 60 | 0.110 |
Why?
|
| Cerebrospinal Fluid Leak | 1 | 2013 | 22 | 0.110 |
Why?
|
| Subdural Effusion | 2 | 2003 | 6 | 0.110 |
Why?
|
| Astrocytoma | 1 | 2013 | 15 | 0.110 |
Why?
|
| Lumbosacral Plexus | 1 | 2013 | 4 | 0.110 |
Why?
|
| Central Cord Syndrome | 1 | 2013 | 1 | 0.100 |
Why?
|
| Body Mass Index | 1 | 2015 | 431 | 0.100 |
Why?
|
| Intraoperative Care | 2 | 2012 | 38 | 0.100 |
Why?
|
| Chondrocytes | 3 | 2006 | 155 | 0.100 |
Why?
|
| Odontoid Process | 1 | 1992 | 9 | 0.100 |
Why?
|
| Logistic Models | 1 | 2013 | 368 | 0.100 |
Why?
|
| Multivariate Analysis | 1 | 2013 | 309 | 0.100 |
Why?
|
| Tarlov Cysts | 1 | 2012 | 1 | 0.100 |
Why?
|
| Prone Position | 1 | 2012 | 31 | 0.100 |
Why?
|
| Monitoring, Intraoperative | 1 | 2012 | 32 | 0.100 |
Why?
|
| Glioblastoma | 1 | 2012 | 12 | 0.100 |
Why?
|
| Calcinosis | 1 | 2012 | 38 | 0.100 |
Why?
|
| Evidence-Based Medicine | 1 | 2013 | 162 | 0.100 |
Why?
|
| Self Report | 1 | 2013 | 207 | 0.100 |
Why?
|
| Lipomatosis | 1 | 1992 | 3 | 0.090 |
Why?
|
| Guidelines as Topic | 1 | 2012 | 56 | 0.090 |
Why?
|
| Abdominal Injuries | 1 | 2011 | 3 | 0.090 |
Why?
|
| Psoas Muscles | 1 | 2011 | 5 | 0.090 |
Why?
|
| Prednisone | 1 | 1992 | 63 | 0.090 |
Why?
|
| Brain Neoplasms | 1 | 2012 | 84 | 0.090 |
Why?
|
| Polyradiculopathy | 1 | 2011 | 4 | 0.090 |
Why?
|
| Computer Simulation | 2 | 2010 | 176 | 0.090 |
Why?
|
| Neurologic Examination | 3 | 1998 | 99 | 0.090 |
Why?
|
| Case-Control Studies | 2 | 2018 | 567 | 0.090 |
Why?
|
| Visual Analog Scale | 3 | 2017 | 84 | 0.080 |
Why?
|
| Transplantation, Homologous | 2 | 2003 | 260 | 0.080 |
Why?
|
| Endorphins | 3 | 1984 | 3 | 0.080 |
Why?
|
| Clinical Trials as Topic | 2 | 2014 | 196 | 0.080 |
Why?
|
| Pain, Postoperative | 1 | 2013 | 313 | 0.080 |
Why?
|
| Endoscopes | 2 | 2007 | 8 | 0.080 |
Why?
|
| Breast Neoplasms | 1 | 2013 | 381 | 0.080 |
Why?
|
| Polymethacrylic Acids | 1 | 2009 | 5 | 0.080 |
Why?
|
| Ribs | 1 | 2009 | 14 | 0.080 |
Why?
|
| Fractures, Compression | 1 | 2009 | 7 | 0.080 |
Why?
|
| Cerebral Angiography | 1 | 2009 | 31 | 0.080 |
Why?
|
| Mycetoma | 1 | 1989 | 1 | 0.080 |
Why?
|
| Cranial Sinuses | 1 | 1989 | 2 | 0.080 |
Why?
|
| Elastic Modulus | 1 | 2009 | 10 | 0.080 |
Why?
|
| Compressive Strength | 1 | 2009 | 17 | 0.080 |
Why?
|
| Motion | 1 | 2009 | 20 | 0.080 |
Why?
|
| Ultrasonography | 2 | 2007 | 221 | 0.070 |
Why?
|
| Stress, Mechanical | 1 | 2009 | 155 | 0.070 |
Why?
|
| Weight-Bearing | 1 | 2009 | 157 | 0.070 |
Why?
|
| Epidural Space | 2 | 2022 | 20 | 0.070 |
Why?
|
| Aging | 2 | 2011 | 1503 | 0.070 |
Why?
|
| Thoracic Surgery, Video-Assisted | 1 | 2008 | 21 | 0.070 |
Why?
|
| Meningioma | 2 | 2000 | 17 | 0.070 |
Why?
|
| Prognosis | 3 | 2016 | 695 | 0.070 |
Why?
|
| Animals | 7 | 2003 | 3504 | 0.070 |
Why?
|
| Sensation Disorders | 2 | 1999 | 10 | 0.070 |
Why?
|
| Health Status | 1 | 2008 | 198 | 0.070 |
Why?
|
| Neural Tube Defects | 1 | 2007 | 6 | 0.070 |
Why?
|
| Equipment Design | 1 | 2007 | 126 | 0.070 |
Why?
|
| Dissection | 1 | 2007 | 24 | 0.070 |
Why?
|
| Microscopy | 1 | 2007 | 14 | 0.070 |
Why?
|
| Laser Therapy | 1 | 2006 | 10 | 0.070 |
Why?
|
| Spinal Canal | 1 | 2006 | 6 | 0.070 |
Why?
|
| Electronarcosis | 1 | 1984 | 1 | 0.060 |
Why?
|
| Cerebral Ventriculography | 1 | 1984 | 1 | 0.060 |
Why?
|
| Reproducibility of Results | 2 | 2018 | 619 | 0.050 |
Why?
|
| Synovial Cyst | 1 | 2004 | 3 | 0.050 |
Why?
|
| Radiography, Interventional | 1 | 2003 | 14 | 0.050 |
Why?
|
| History, 18th Century | 1 | 2003 | 4 | 0.050 |
Why?
|
| History, Ancient | 1 | 2003 | 3 | 0.050 |
Why?
|
| Chemotaxis | 1 | 2003 | 5 | 0.050 |
Why?
|
| Tissue Preservation | 1 | 2003 | 3 | 0.050 |
Why?
|
| Contrast Media | 3 | 2012 | 58 | 0.050 |
Why?
|
| Antitubercular Agents | 1 | 2003 | 12 | 0.050 |
Why?
|
| Mesoderm | 1 | 2003 | 18 | 0.050 |
Why?
|
| History, 20th Century | 1 | 2003 | 31 | 0.050 |
Why?
|
| Cell Division | 1 | 2003 | 80 | 0.050 |
Why?
|
| Osteoclasts | 1 | 2003 | 22 | 0.050 |
Why?
|
| Combined Modality Therapy | 2 | 2015 | 286 | 0.050 |
Why?
|
| Pregnancy Complications | 1 | 2003 | 44 | 0.050 |
Why?
|
| Bone Matrix | 1 | 2003 | 19 | 0.050 |
Why?
|
| Polymethyl Methacrylate | 1 | 2002 | 10 | 0.050 |
Why?
|
| Models, Animal | 1 | 2003 | 108 | 0.050 |
Why?
|
| Mouth | 1 | 2002 | 14 | 0.050 |
Why?
|
| Osteoblasts | 1 | 2003 | 57 | 0.050 |
Why?
|
| Pharynx | 1 | 2002 | 12 | 0.050 |
Why?
|
| Rabbits | 1 | 2003 | 178 | 0.050 |
Why?
|
| Bone Remodeling | 1 | 2003 | 50 | 0.050 |
Why?
|
| Transplantation, Autologous | 1 | 2003 | 150 | 0.050 |
Why?
|
| Consensus | 1 | 2023 | 91 | 0.050 |
Why?
|
| Neck Pain | 1 | 2002 | 28 | 0.050 |
Why?
|
| Pregnancy | 1 | 2003 | 327 | 0.050 |
Why?
|
| Bone Regeneration | 1 | 2003 | 69 | 0.050 |
Why?
|
| Osteogenesis | 1 | 2003 | 104 | 0.050 |
Why?
|
| Bone Cements | 1 | 2002 | 85 | 0.050 |
Why?
|
| Survival Rate | 2 | 2013 | 294 | 0.050 |
Why?
|
| Bacterial Infections | 2 | 2004 | 52 | 0.050 |
Why?
|
| Multicenter Studies as Topic | 1 | 2021 | 41 | 0.050 |
Why?
|
| United States | 2 | 2017 | 1935 | 0.040 |
Why?
|
| Surveys and Questionnaires | 2 | 2015 | 1083 | 0.040 |
Why?
|
| Molecular Biology | 1 | 2000 | 11 | 0.040 |
Why?
|
| Growth Substances | 1 | 2000 | 28 | 0.040 |
Why?
|
| Granuloma | 1 | 2000 | 13 | 0.040 |
Why?
|
| Collagen | 1 | 2000 | 81 | 0.040 |
Why?
|
| Cell Survival | 1 | 2000 | 117 | 0.040 |
Why?
|
| Meningeal Neoplasms | 1 | 2000 | 15 | 0.040 |
Why?
|
| Cell Movement | 1 | 2000 | 80 | 0.040 |
Why?
|
| Proteoglycans | 1 | 2000 | 131 | 0.040 |
Why?
|
| Sarcoidosis | 1 | 2000 | 13 | 0.040 |
Why?
|
| Inflammation Mediators | 1 | 2000 | 66 | 0.040 |
Why?
|
| Immobilization | 1 | 1999 | 13 | 0.040 |
Why?
|
| Orthopedic Fixation Devices | 2 | 1997 | 19 | 0.040 |
Why?
|
| Myelography | 2 | 1992 | 5 | 0.040 |
Why?
|
| Thoracotomy | 1 | 1998 | 26 | 0.040 |
Why?
|
| Observer Variation | 1 | 2018 | 95 | 0.040 |
Why?
|
| Survival Analysis | 1 | 1998 | 234 | 0.040 |
Why?
|
| Surgeons | 1 | 2018 | 86 | 0.030 |
Why?
|
| Inpatients | 1 | 2017 | 121 | 0.030 |
Why?
|
| Heparin | 2 | 1987 | 21 | 0.030 |
Why?
|
| Dogs | 3 | 1993 | 147 | 0.030 |
Why?
|
| Wound Healing | 1 | 1997 | 153 | 0.030 |
Why?
|
| Radioimmunoassay | 3 | 1984 | 19 | 0.030 |
Why?
|
| Osteomyelitis | 2 | 1992 | 18 | 0.030 |
Why?
|
| Malpractice | 1 | 2015 | 11 | 0.030 |
Why?
|
| Prevalence | 1 | 2016 | 431 | 0.030 |
Why?
|
| Longitudinal Ligaments | 1 | 1994 | 1 | 0.030 |
Why?
|
| Gelatin Sponge, Absorbable | 1 | 1994 | 3 | 0.030 |
Why?
|
| Fascia | 1 | 1994 | 9 | 0.030 |
Why?
|
| Patient-Centered Care | 1 | 2015 | 43 | 0.030 |
Why?
|
| Cell Transplantation | 1 | 1994 | 21 | 0.030 |
Why?
|
| Pleural Effusion | 1 | 1994 | 12 | 0.030 |
Why?
|
| Risk | 1 | 2015 | 202 | 0.030 |
Why?
|
| Neurilemmoma | 1 | 1994 | 15 | 0.030 |
Why?
|
| Hospitalization | 1 | 2016 | 295 | 0.030 |
Why?
|
| Delivery of Health Care | 1 | 2015 | 140 | 0.030 |
Why?
|
| SEER Program | 1 | 2013 | 41 | 0.030 |
Why?
|
| Contraindications | 1 | 1993 | 30 | 0.030 |
Why?
|
| Child | 1 | 1997 | 1180 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2016 | 830 | 0.030 |
Why?
|
| ROC Curve | 1 | 2013 | 131 | 0.030 |
Why?
|
| Transcranial Magnetic Stimulation | 1 | 2012 | 11 | 0.020 |
Why?
|
| Disease Management | 1 | 2013 | 91 | 0.020 |
Why?
|
| Spinal Injuries | 1 | 1993 | 23 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 1993 | 77 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2013 | 339 | 0.020 |
Why?
|
| Surgical Flaps | 1 | 1992 | 48 | 0.020 |
Why?
|
| Pleura | 1 | 1991 | 9 | 0.020 |
Why?
|
| Morbidity | 1 | 2011 | 50 | 0.020 |
Why?
|
| Surgical Procedures, Operative | 1 | 1991 | 27 | 0.020 |
Why?
|
| Fractures, Bone | 1 | 1992 | 73 | 0.020 |
Why?
|
| Orthopedics | 1 | 1993 | 113 | 0.020 |
Why?
|
| Debridement | 2 | 2004 | 104 | 0.020 |
Why?
|
| Scapula | 1 | 1991 | 90 | 0.020 |
Why?
|
| Muscular Atrophy | 1 | 2010 | 12 | 0.020 |
Why?
|
| beta-Endorphin | 3 | 1984 | 5 | 0.020 |
Why?
|
| Arthrodesis | 1 | 2010 | 39 | 0.020 |
Why?
|
| Movement Disorders | 1 | 2010 | 67 | 0.020 |
Why?
|
| Arthritis, Rheumatoid | 1 | 1992 | 251 | 0.020 |
Why?
|
| Pseudallescheria | 1 | 1989 | 1 | 0.020 |
Why?
|
| Endpoint Determination | 1 | 2009 | 20 | 0.020 |
Why?
|
| Rats | 2 | 1987 | 628 | 0.020 |
Why?
|
| Spondylitis, Ankylosing | 1 | 2008 | 20 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2009 | 553 | 0.020 |
Why?
|
| Blood Coagulation | 1 | 1987 | 20 | 0.020 |
Why?
|
| Crystallization | 1 | 2006 | 3 | 0.020 |
Why?
|
| Chondrocalcinosis | 1 | 2006 | 3 | 0.020 |
Why?
|
| Neovascularization, Physiologic | 1 | 2006 | 21 | 0.020 |
Why?
|
| Preoperative Care | 1 | 2006 | 119 | 0.020 |
Why?
|
| Age Distribution | 1 | 2006 | 83 | 0.020 |
Why?
|
| Craniotomy | 1 | 1985 | 24 | 0.020 |
Why?
|
| Synovial Membrane | 1 | 2006 | 56 | 0.020 |
Why?
|
| Central Nervous System Fungal Infections | 1 | 2004 | 2 | 0.010 |
Why?
|
| Cerebral Hemorrhage | 1 | 1985 | 98 | 0.010 |
Why?
|
| Periaqueductal Gray | 1 | 1984 | 1 | 0.010 |
Why?
|
| Stereotaxic Techniques | 1 | 1984 | 15 | 0.010 |
Why?
|
| Ventromedial Hypothalamic Nucleus | 1 | 1984 | 1 | 0.010 |
Why?
|
| Metrizamide | 1 | 1984 | 1 | 0.010 |
Why?
|
| Eating | 1 | 1984 | 57 | 0.010 |
Why?
|
| Pain Management | 1 | 1984 | 142 | 0.010 |
Why?
|
| H-Reflex | 1 | 2001 | 1 | 0.010 |
Why?
|
| Median Nerve | 1 | 2001 | 1 | 0.010 |
Why?
|
| Tibial Nerve | 1 | 2001 | 4 | 0.010 |
Why?
|
| Neural Conduction | 1 | 2001 | 10 | 0.010 |
Why?
|
| Action Potentials | 1 | 2001 | 82 | 0.010 |
Why?
|
| Necrosis | 1 | 2000 | 23 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2001 | 394 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2000 | 328 | 0.010 |
Why?
|
| Work | 1 | 1996 | 6 | 0.010 |
Why?
|
| Extremities | 1 | 1996 | 25 | 0.010 |
Why?
|
| Partial Thromboplastin Time | 2 | 1987 | 6 | 0.010 |
Why?
|
| Antidepressive Agents | 1 | 1996 | 92 | 0.010 |
Why?
|
| Analgesics | 1 | 1996 | 80 | 0.010 |
Why?
|
| Chronic Disease | 1 | 1996 | 403 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 1997 | 375 | 0.010 |
Why?
|
| Equipment Failure | 1 | 1992 | 37 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 1987 | 149 | 0.000 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1987 | 314 | 0.000 |
Why?
|
| Thromboembolism | 1 | 1985 | 17 | 0.000 |
Why?
|
| Drinking | 1 | 1984 | 6 | 0.000 |
Why?
|
| Pulse | 1 | 1984 | 3 | 0.000 |
Why?
|
| Electrodes, Implanted | 1 | 1984 | 22 | 0.000 |
Why?
|
| Body Temperature | 1 | 1984 | 41 | 0.000 |
Why?
|
| Electric Stimulation | 1 | 1984 | 45 | 0.000 |
Why?
|
| Respiration | 1 | 1984 | 32 | 0.000 |
Why?
|
| Behavior, Animal | 1 | 1984 | 50 | 0.000 |
Why?
|
| False Positive Reactions | 1 | 1984 | 33 | 0.000 |
Why?
|
| Blood Pressure | 1 | 1984 | 179 | 0.000 |
Why?
|